412 related articles for article (PubMed ID: 19209092)
1. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
[TBL] [Abstract][Full Text] [Related]
2. Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants.
Tanaka Y; Yokokawa R; Rong HS; Kishino H; Stek JE; Nelson M; Lawrence J
Hum Vaccin Immunother; 2017 Jun; 13(6):1-7. PubMed ID: 28140752
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine.
Dagan R; Igbaria K; Piglansky L; Melamed R; Willems P; Grossi A; Kaufhold A
Pediatr Infect Dis J; 1997 Dec; 16(12):1113-21. PubMed ID: 9427455
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.
Lalwani SK; Agarkhedkar S; Sundaram B; Mahantashetti NS; Malshe N; Agarkhedkar S; Van Der Meeren O; Mehta S; Karkada N; Han HH; Mesaros N
Hum Vaccin Immunother; 2017 Jan; 13(1):120-127. PubMed ID: 27629913
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines.
Rennels MB; Reed GF; Decker MD; Edwards KM; Pichichero ME; Deloria MA; Englund JA; Anderson EL; Steinhoff MC; Deforest A
Pediatrics; 1995 Sep; 96(3 Pt 2):576-9. PubMed ID: 7659479
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age.
Arístegui J; Dal-Ré R; Garrote E; González A; Arrate JP; Pérez A
Vaccine; 1998 Dec; 16(20):1976-81. PubMed ID: 9796053
[TBL] [Abstract][Full Text] [Related]
7. [Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain].
González López A; Arístegui Fernández J; Díez-Delgado J; Dal-Ré Saavedra R
An Esp Pediatr; 1998 Feb; 48(2):132-7. PubMed ID: 9577019
[TBL] [Abstract][Full Text] [Related]
8. Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group.
Markwick AJ; Rennels MB; Zito ET; Wade MS; Mack ME
Pediatr Infect Dis J; 1998 Oct; 17(10):913-8. PubMed ID: 9802635
[TBL] [Abstract][Full Text] [Related]
9. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents.
Vesikari T; Wysocki J; Beeslaar J; Eiden J; Jiang Q; Jansen KU; Jones TR; Harris SL; O'Neill RE; York LJ; Perez JL
J Pediatric Infect Dis Soc; 2016 Jun; 5(2):180-7. PubMed ID: 26803328
[TBL] [Abstract][Full Text] [Related]
11. Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine.
Halsey NA; Blatter M; Bader G; Thoms ML; Willingham FF; O'Donovan JC; Pakula L; Berut F; Reisinger KS; Meschievitz C
Pediatr Infect Dis J; 1997 Jul; 16(7):675-9. PubMed ID: 9239772
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial.
Capeding MR; Cadorna-Carlos J; Book-Montellano M; Ortiz E
Bull World Health Organ; 2008 Jun; 86(6):443-51. PubMed ID: 18568273
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821
[TBL] [Abstract][Full Text] [Related]
14. Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life.
Steiner M; Ramakrishnan G; Gartner B; Van Der Meeren O; Jacquet JM; Schuster V
BMC Infect Dis; 2010 Jan; 10():9. PubMed ID: 20078876
[TBL] [Abstract][Full Text] [Related]
15. Development and efficacy assessment of combination vaccines, with emphasis on acellular pertussis.
Hauser P; De Grave D; Zepp F; Poolman J; Slaoui M
Dev Biol Stand; 1998; 95():251-5. PubMed ID: 9855439
[TBL] [Abstract][Full Text] [Related]
16. Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP~T Vaccination in a 3-, 5- and 11- to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination.
Virta M; Soininen A; Patel DM; Petit C; Tabar C; Lyabis O
Pediatr Infect Dis J; 2021 Jan; 40(1):e28-e30. PubMed ID: 33284254
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.
Halperin SA; Davies HD; Barreto L; Guasparini R; Meekison W; Humphreys G; Eastwood BJ
J Pediatr; 1997 Apr; 130(4):525-31. PubMed ID: 9108847
[TBL] [Abstract][Full Text] [Related]
18. Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease?
Granoff DM; Rappuoli R
Dev Biol Stand; 1997; 89():379-89. PubMed ID: 9272376
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules. Multicenter Working Group.
Giammanco G; Moiraghi A; Zotti C; Pignato S; Li Volti S; Giammanco A; Soncini R
Vaccine; 1998 Apr; 16(7):722-6. PubMed ID: 9562692
[TBL] [Abstract][Full Text] [Related]
20. Diphtheria, tetanus and whole cell pertussis vaccine combined with hepatitis B vaccines: a comparison of two doses (10 microg and 5 microg).
Chiu HH; Huang LM; Lee PI; Safary A; Lee CY
Pediatr Infect Dis J; 1998 Mar; 17(3):206-11. PubMed ID: 9535247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
